2000
DOI: 10.1097/00003226-200009000-00013
|View full text |Cite
|
Sign up to set email alerts
|

Advances in the Management of Keratomycosis and Acanthamoeba Keratitis

Abstract: Although there has been steady progress in the management of both infections, continued research is the way to define more effective medical and surgical therapy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
38
0
3

Year Published

2003
2003
2022
2022

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 51 publications
(41 citation statements)
references
References 82 publications
0
38
0
3
Order By: Relevance
“…Unfortunately, side effects limited the intravenous use of this drug in many cases, as compared to the rather marginal intravitreal levels achieved after intravenous administration. However, it was O'Day and Head [1] who later demonstrated that the triazole agent fluconazole was able to achieve significant levels of this drug in the vitreous after systemic administration. This newer antifungal agent was therefore the first showing intraocular penetration due to lower protein binding and improved water solubility.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Unfortunately, side effects limited the intravenous use of this drug in many cases, as compared to the rather marginal intravitreal levels achieved after intravenous administration. However, it was O'Day and Head [1] who later demonstrated that the triazole agent fluconazole was able to achieve significant levels of this drug in the vitreous after systemic administration. This newer antifungal agent was therefore the first showing intraocular penetration due to lower protein binding and improved water solubility.…”
Section: Discussionmentioning
confidence: 99%
“…Keratitis is the most frequent presentation [1] , but the orbit, lids and lacrimal apparatus, conjunctiva, sclera and intraocular structures may also be involved. Comprehensive reviews of fungal diseases have been published by Behrens-Baumann [2] and Klotz et al [3] .…”
Section: Introductionmentioning
confidence: 99%
“…Corticosteroids suppress the activity of the macrophage, which is essential in scavenging and destroying the amoeba [6]. Thus, in general, it is recommended to delay and limit steroid use as much as possible, utilizing it in combination with antiamoebic agents and only in those patients with severe pain, scleritis, or severe anterior-chamber inflammation [38,42,43]. In patients with severe scleral involvement, systemic immunosuppression may be necessary and has been described using oral steroids, cyclosporine, and azathioprine [44].…”
Section: Medical Treatmentmentioning
confidence: 99%
“…6 However, polyene antibiotics are generally toxic to the cornea, 7,8 and although no toxicity of azole derivatives has been reported, azole-resistant fungi are gradually emerging. 7,9 Recently, a new class of antifungal agent, candin derivatives, has become available.…”
mentioning
confidence: 99%